ArticleOncotarget2016

Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.

I-Ling Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.